Structure
| PDB | Resolution (Å) | PDB name |
|---|---|---|
| 3GLR | 1.8 | Crystal Structure of human SIRT3 with acetyl-lysine AceCS2 peptide |
| 3GLT | 2.1 | Crystal Structure of Human SIRT3 with ADPR bound to the AceCS2 peptide containing a thioacetyl lysine |
| 3GLU | 2.5 | Crystal Structure of Human SIRT3 with AceCS2 peptide |
| 4BVE | 2.05 | CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THIOALKYLIMIDATE FORMED FROM THIO-ACETYL-LYSINE ACS2-PEPTIDE |
| 4BVF | 2.7 | CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THIOALKYLIMIDATE FORMED FROM THIO-ACETYL-LYSINE ACS2-PEPTIDE CRYSTALLIZED IN PRESENCE OF THE INHIBITOR EX-527 |
| 4BVG | 2.5 | CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH NATIVE ALKYLIMIDATE FORMED FROM ACETYL-LYSINE ACS2-PEPTIDE CRYSTALLIZED IN PRESENCE OF THE INHIBITOR EX-527 |
| 4C78 | 2.0 | Complex of human Sirt3 with Bromo-Resveratrol and ACS2 peptide |
| 5Y4H | 2.6 | Human SIRT3 in complex with halistanol sulfate |
| 5YTK | 2.7 | Crystal structure of SIRT3 bound to a leucylated AceCS2 |
